ARCHIVES

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992